LTP Stock Chart & Stats
AU$0.40
AU$0.06(7.38%)
At close: 4:00 PM EST
AU$0.40
AU$0.06(7.38%)
Day’s Range― - ―
52-Week RangeAU$0.31 - AU$0.81
Previous CloseN/A
Volume558.33K
Average Volume (3M)900.17K
Market Cap
AU$89.07M
Enterprise ValueAU$20.68M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.40
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding181,777,590
10 Day Avg. Volume608,036
30 Day Avg. Volume900,169
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LTR Pharma Limited News
LTP FAQ
What was LTR Pharma Limited’s price range in the past 12 months?
LTR Pharma Limited lowest share price was AU$0.30 and its highest was AU$0.81 in the past 12 months.
What is LTR Pharma Limited’s market cap?
LTR Pharma Limited’s market cap is AU$89.07M.
When is LTR Pharma Limited’s upcoming earnings report date?
LTR Pharma Limited’s upcoming earnings report date is Aug 27, 2026 which is in 42 days.
How were LTR Pharma Limited’s earnings last quarter?
LTR Pharma Limited released its earnings results on Feb 25, 2026. The company reported -AU$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.032.
Is LTR Pharma Limited overvalued?
According to Wall Street analysts LTR Pharma Limited’s price is currently Overvalued.
Does LTR Pharma Limited pay dividends?
LTR Pharma Limited does not currently pay dividends.
What is LTR Pharma Limited’s EPS estimate?
LTR Pharma Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LTR Pharma Limited have?
LTR Pharma Limited has 181,777,590 shares outstanding.
What happened to LTR Pharma Limited’s price movement after its last earnings report?
LTR Pharma Limited reported an EPS of -AU$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.122%.
Which hedge fund is a major shareholder of LTR Pharma Limited?
Currently, no hedge funds are holding shares in AU:LTP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
LTR Pharma Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:LTP Sentiment 97%
Sector Average 67%
Sector Average 67%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-69.18%
12-Months-Change
Fundamentals
Return on Equity
-29.27%
Trailing 12-Months
Asset Growth
-21.33%
Trailing 12-Months
Technical Analysis
Amplia Therapeutics
―
Immutep Ltd
―
Prescient Therapeutics Limited
―
Botanix Pharmaceuticals Limited
―
Radiopharm Theranostics Limited
―